L. Marks

621 total citations
23 papers, 448 citations indexed

About

L. Marks is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, L. Marks has authored 23 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in L. Marks's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (4 papers) and Renal and Vascular Pathologies (3 papers). L. Marks is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (4 papers) and Renal and Vascular Pathologies (3 papers). L. Marks collaborates with scholars based in United States and Japan. L. Marks's co-authors include A. John MacLennan, Marco Pfeifer, Amanda A. Gaskin, Claus G. Roehrborn, Richard C. Harkaway, Nancy Lee, Robert B. Levy, Marieta Barrow Heaton, Emily N. Vinson and Eckhard R. Podack and has published in prestigious journals such as JAMA, Journal of Neuroscience and Neuroscience.

In The Last Decade

L. Marks

23 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Marks United States 10 154 127 111 84 61 23 448
Tracey Shipman United States 11 222 1.4× 117 0.9× 117 1.1× 60 0.7× 27 0.4× 13 679
Gerson Lüdecke Germany 11 357 2.3× 142 1.1× 76 0.7× 91 1.1× 136 2.2× 29 755
Kelly E. Hagler United States 6 349 2.3× 188 1.5× 56 0.5× 131 1.6× 51 0.8× 9 696
Ayano Tokunaga Japan 6 168 1.1× 81 0.6× 26 0.2× 45 0.5× 55 0.9× 7 384
JJ H. Zhang United States 9 177 1.1× 95 0.7× 84 0.8× 162 1.9× 144 2.4× 22 628
Ali Jalali United States 12 302 2.0× 37 0.3× 84 0.8× 60 0.7× 11 0.2× 40 602
C.M. Garcia United States 10 149 1.0× 77 0.6× 20 0.2× 35 0.4× 10 0.2× 13 379
Lanying Song United States 16 557 3.6× 80 0.6× 44 0.4× 71 0.8× 11 0.2× 22 749
Annalisa Vetro Italy 20 524 3.4× 33 0.3× 60 0.5× 32 0.4× 27 0.4× 51 1.0k
Santiago Oya Spain 15 132 0.9× 224 1.8× 38 0.3× 93 1.1× 12 0.2× 23 552

Countries citing papers authored by L. Marks

Since Specialization
Citations

This map shows the geographic impact of L. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Marks more than expected).

Fields of papers citing papers by L. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Marks. The network helps show where L. Marks may publish in the future.

Co-authorship network of co-authors of L. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of L. Marks. A scholar is included among the top collaborators of L. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Marks. L. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Ryan & L. Marks. (2019). Targeted and Systematic Biopsy for Diagnosis and Management of Prostate Cancer. Clinical Oncology. 32(3). 144–148. 2 indexed citations
2.
Priester, Alan, Le Zhang, Holden H. Wu, et al.. (2019). A tissue-mimicking prostate phantom for 980 nm laser interstitial thermal therapy. International Journal of Hyperthermia. 36(1). 992–1001. 14 indexed citations
3.
Rakow‐Penner, Rebecca, Nathan S. White, J. Kellogg Parsons, et al.. (2015). Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension. Prostate Cancer and Prostatic Diseases. 18(1). 81–85. 22 indexed citations
4.
Kamrava, Mitchell, Min Sung Chung, Shane Mesko, et al.. (2013). Correlation of Quantitative Diffusion-Weighted and Dynamic Contrast-Enhanced MRI Parameters With NCCN Risk Group, Gleason Score, and Maximum Tumor Diameter in Prostate Cancer. Practical Radiation Oncology. 3(2). S4–S4. 6 indexed citations
5.
Groskopf, Jack, Ina L. Deras, Amy Blase, et al.. (2006). SPECIFICITY OF THE APTIMA® PCA3 ASSAY FOR PROSTATE CANCER. European Urology Supplements. 5(2). 240–240. 1 indexed citations
6.
Roehrborn, Claus G., L. Marks, & Richard C. Harkaway. (2005). Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners. Prostate Cancer and Prostatic Diseases. 9(1). 30–34. 39 indexed citations
7.
Marks, L. & Robert B. Levy. (2004). The cytotoxic potential of regulatory T cells: what has been learned from gene knockout model systems?1. Transplantation. 77(Supplement). S19–S22. 5 indexed citations
8.
Veltri, Robert W., Michael Craig Miller, L. Marks, et al.. (2004). Stromal–epithelial measurements of prostate cancer in native Japanese and Japanese-American men. Prostate Cancer and Prostatic Diseases. 7(3). 232–237. 6 indexed citations
9.
Marks, L., Norman H. Altman, Eckhard R. Podack, & Robert B. Levy. (2004). Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients. Transplantation. 77(6). 804–812. 20 indexed citations
10.
11.
Marks, L., et al.. (1999). Use of a shape-memory alloy (nitinol) in a removable prostate stent.. PubMed. 5(4). 226–30. 7 indexed citations
12.
Mikolajczyk, S D, Lisa S. Millar, Kathy M. Marker, et al.. (1999). Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.. PubMed. 59(16). 3927–30. 30 indexed citations
13.
Marks, L., Alan W. Partin, Glenn J. Gormley, et al.. (1998). RE: PROSTATE TISSUE COMPOSITION AND RESPONSE TO FINASTERIDE IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 160(1). 134–134. 2 indexed citations
14.
MacLennan, A. John, et al.. (1997). Embryonic expression pattern of H218, a G-protein coupled receptor homolog, suggests roles in early mammalian nervous system development. Neuroscience. 79(1). 217–224. 34 indexed citations
15.
MacLennan, A. John, et al.. (1997). Immunohistochemical Localization of Netrin-1 in the Embryonic Chick Nervous System. Journal of Neuroscience. 17(14). 5466–5479. 45 indexed citations
16.
MacLennan, A. John, et al.. (1996). Immunohistochemical localization of ciliary neurotrophic factor receptor alpha expression in the rat nervous system.. PubMed. 16(2). 621–30. 130 indexed citations
17.
Marks, L., et al.. (1982). Renal Carcinoma Masquerading as Renal Tuberculosis. British Journal of Urology. 54(2). 192–192. 2 indexed citations
18.
Maxwell, Morton H., et al.. (1978). Maximal Discrimination of Renovascular from Essential Hypertension by the Saralasin Test. Clinical Science. 55(s4). 297s–299s. 9 indexed citations
19.
Marks, L.. (1976). Renal artery repair. Normal blood pressure and renal function 20 years later. JAMA. 236(17). 1972–1973. 1 indexed citations
20.
Marks, L. & Eugene F. Poutasse. (1973). Hypertension from Renal Tuberculosis: Operative Cure Predicted by Renal Vein Renin. The Journal of Urology. 109(2). 149–151. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracey Shipman Breakdown of academic impact, for papers by Gerson Lüdecke Breakdown of academic impact, for papers by Kelly E. Hagler Breakdown of academic impact, for papers by Ayano Tokunaga Breakdown of academic impact, for papers by JJ H. Zhang Breakdown of academic impact, for papers by Ali Jalali Breakdown of academic impact, for papers by C.M. Garcia Breakdown of academic impact, for papers by Lanying Song Breakdown of academic impact, for papers by Annalisa Vetro Breakdown of academic impact, for papers by Santiago Oya
Rankless by CCL
2026